Literature DB >> 16323612

Overall obesity and abdominal obesity and the risk of metabolic abnormalities.

S W Lai1, K C Ng.   

Abstract

BACKGROUND: Obesity is a risk factor for multiple chronic diseases. AIM: To determine the relationship between overall or abdominal obesity and various metabolic abnormalities.
METHODS: The medical records of participants undergoing examination from January 2000 to December 2002 were analysed. Body mass index (BMI; kg/m2) for overall obesity and waist circumference (WC; cm) indicating abdominal obesity were measured. Four groups were studied: (1) BMI < 27kg/m2, WC: female < 80cm or male < 90cm; (2) BMI > or = 27kg/m2, WC: female < 80cm or male < 90cm; (3) BMI < 27kg/m2, WC: female > or = 80cm or male > or = 90cm; (4) BMI > or = 27kg/m2, WC: female > or = 80cm or male > or = 90cm.
RESULTS: There were 1,342 (44%) females and 1,711 males aged 20-87 years. The prevalence of overall obesity was 20.4% and abdominal obesity was 48%. Obese subjects had more metabolic abnormalities than non-obese in terms of risk of hypertension, hyperglycaemia, hypercholesterolaemia, hypertriglyceridaemia, high level of LDL, low level of HDL, high ratio of TC/HDL, hyperuricaemia and fatty liver.
CONCLUSIONS: As overall and abdominal obesity may predict clustering of metabolic abnormalities we suggest that BMI and WC are convenient methods for assessing metabolic abnormalities in primary healthcare settings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16323612     DOI: 10.1007/bf02914549

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  29 in total

1.  The association of cardiovascular disease risk factors with abdominal obesity in Canada. Canadian Heart Health Surveys Research Group.

Authors:  B A Reeder; A Senthilselvan; J P Després; A Angel; L Liu; H Wang; S W Rabkin
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

2.  A comparative analysis of weight to height and waist to hip circumference indices as indicators of the presence of cardiovascular disease risk factors. Canadian Heart Health Surveys Research Group.

Authors:  M Ledoux; J Lambert; B A Reeder; J P Després
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

3.  Waist circumference vs body mass index for prediction of disease risk in postmenopausal women.

Authors:  R E Van Pelt; E M Evans; K B Schechtman; A A Ehsani; W M Kohrt
Journal:  Int J Obes Relat Metab Disord       Date:  2001-08

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Serum uric acid and related factors in 500 hospitalized subjects.

Authors:  F Saggiani; S Pilati; G Targher; P Branzi; M Muggeo; E Bonora
Journal:  Metabolism       Date:  1996-12       Impact factor: 8.694

6.  Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly: their relation with cardiovascular risk factors.

Authors:  E Turcato; O Bosello; V Di Francesco; T B Harris; E Zoico; L Bissoli; E Fracassi; M Zamboni
Journal:  Int J Obes Relat Metab Disord       Date:  2000-08

7.  Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee.

Authors: 
Journal:  BMJ       Date:  1993-12-11

8.  Summary of the national guidelines for the diagnosis and management of lipid disorders in Taiwan. The experts panel.

Authors: 
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1995-01

9.  Associated risk factors of diabetes in Kin-Hu, Kinmen.

Authors:  P Chou; M J Liao; S T Tsai
Journal:  Diabetes Res Clin Pract       Date:  1994-12-31       Impact factor: 5.602

10.  Epidemiology of obesity in elderly people.

Authors:  C C Lin; T C Li; S W Lai; C I Li; K C Wanga; C K Tan; K C Ng; C S Liu
Journal:  Yale J Biol Med       Date:  1999 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.